Pharmaceutical Technology

JUNE 29, 2022

For cell and gene therapy applications, you need a variety of speciality enzymes of the highest purity, specificity, and consistency. Developing best-in-class speciality enzymes. In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market.

Specialization 118

Specialization Biopharma B2B Sales Manufacturing 118

The Marketing Advantage

MAY 8, 2023

Lack of Data and/or Proxies There is typically little to no competitive data available With over 95% of the over 7,000 estimated rare diseases having no treatment, these products typically have no competition and thus no competitive data. This, in turn, calls for a more expert and specialized sales force.

Sales 52

Sales Physicians Consulting Education 52

Clarivate

DECEMBER 6, 2022

In a fiercely competitive U.S. While marquee IDNs attract national headlines, these smaller systems reflect how markets are adjusting to an increasingly value-based and competitive landscape. ChristianaCare’s future expansion plans could escalate the competition between Highmark and UPMC. ChristianaCare, Wilmington, Delaware.

Networking 52

Networking Healthcare Healthcare Competition 52

European Pharmaceutical Review

JANUARY 9, 2023

In the first 11 months of 2022, biopharma M&A value dropped by 42 percent compared to 2021, with Pfizer’s acquisition of Biohaven , the single largest deal up to December 2022. Alliances were a significant focus for biopharma and companies’ M&A strategies in 2022. Biopharma alone held over $1.4

Biopharma 90

Biopharma Specialization Leads Competition 90

European Pharmaceutical Review

DECEMBER 21, 2022

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure.

Manufacturing 73

Manufacturing Pharmaceutical Healthcare Healthcare 73

Pharmaceutical Technology

JANUARY 25, 2023

Although expert opinions differ on the future of special purpose acquisition companies (SPACs), some companies are continuing to explore their use. In December 2022, AEON Biopharma, a biopharmaceutical company, announced its plans to go public through a merger with the SPAC Priveterra Acquisition Corp. Download our free whitepaper.

Marketing 69

Marketing Biopharma Pharma Competition 69